Ms. Obermaier has been a director since June 2024. From 2019 to August 2024, she was a senior executive at Microsoft Corporation, most recently in the position of Chief Growth Officer and VP, Strategic Initiatives for Microsoft's $12 billion Global Health Life Sciences division. She identified emerging opportunities and led Microsoft's efforts to mobilize and activate commercial resources to capture market share. She supports our Board with her consulting expertise and guidance in driving strategies for business transformation that deliver scaled global and profitable growth. Key Qualifications Growing Consulting and Global Services Ms. Obermaier was a senior executive at the world's second largest technology and consulting company helping build its global healthcare and life sciences business, skillsets which help ASGN's own growing consulting business in the United States and globally. Advisory Roles Director, Applied Information Sciences, a private mid-size commercial and government IT technology provider Education Bachelor of Science in Biology Massachusetts Institute of Technology Masters in Business Administration The Darden School, University of Virginia Career Highlights Chief Growth Officer and VP, Strategic Initiatives , Global Health Life Sciences, Microsoft Corporation (2023 to 2024); VP, U.S. Health and Life Sciences (2019 2023) Founder and CEO , Resigility, a strategic advisory and information management services firm (2015 2019) VP, General Manager and other roles, Iqvia (2009 2015) Lead partner and chief strategy officer of business units and other roles, Unisys Corporation (2001 2009) Washington Exec's Top Health Care Execs to Watch Award (2022) Women in Technology Stem Leadership Award (2021) Fierce Healthcare's 2021 class of Women of Influence Award (2021) Northern Virginia Technology Council Tech100 Award recipient (2020)